WilmerHale Shortlisted for Life Sciences IP Litigation Firm of the Year at the 2026 LSPN Awards

 WilmerHale Shortlisted for Life Sciences IP Litigation Firm of the Year at the 2026 LSPN Awards

Recognition

Related Solutions

Clients trust us to protect their most important intellectual property matters.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.

WilmerHale has been shortlisted for Life Sciences IP Litigation Firm of the Year in the LSPN Awards USA 2026, which recognize excellence, innovation and leadership across the life sciences intellectual property community.

The LSPN Awards highlight firms and practitioners shaping the future of pharmaceutical and biotechnology patent protection in the United States. WilmerHale’s inclusion highlights the depth of its life sciences IP litigation practice and its work on some of the most challenging disputes in the field.

Finalists for the 2026 awards were selected following a competitive process recognizing outstanding contributions across a wide range of life sciences IP categories. 

Winners will be announced at the LSPN Awards ceremony on April 30, 2026, in Boston.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link. (The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel